Patient Discussion
Make the MenB discussion part of the decision to vaccinate

Do you involve patients and parents in the decision to vaccinate against meningococcal serogroup B disease (MenB)? If it’s not a part of your protocol, you may not be following the latest CDC recommendation.

CDC recently published an updated vaccination schedule with guidelines for meningitis B vaccination.

A primary series is recommended for adolescents not at increased risk age 16–23 years (preferred age 16–18 years) based on shared clinical decision-making.1

The best way to achieve shared clinical decision-making is to have a discussion about MenB. Remember that patients and parents may not know what MenB is—that’s why it’s important for you to start the conversation.

Include the following points in your MenB conversation:

REVIEW what meningococcal disease is, as well as the potential consequences and their rapid progression
LIST the behavioral risk factors that can lead to contracting MenB
EXPLAIN the differences between serogroups ACWY and B and the 2 different types of vaccines
RECOMMEND that your appropriate patients start the MenB vaccination series
REMIND them that MenB vaccines are typically covered by the Affordable Care Act and the Vaccines for Children Program2,3
EMPHASIZE the importance of series completion and schedule their second dose

CDC=Centers for Disease Control and Prevention.

Vaccination may not protect all recipients.

References: 1. Centers for Disease Control and Prevention. Immunization schedules: Recommended child and adolescent immunization schedule for ages 18 years or younger, United States, 2020. https://www.cdc.gov/vaccines/schedules/downloads/child/0-18yrs-child-combined-schedule.pdf. Updated February 3, 2020. Accessed February 6, 2020. 2. Resources for adult vaccination insurance and payment. Centers for Disease Control and Prevention website. https://www.cdc.gov/vaccines/hcp/adults/for-practice/insurance-payment.html. Reviewed May 2, 2016. Accessed March 12, 2020. 3. Centers for Disease Control and Prevention. Advisory Committee on Immunization Practices Vaccines for Children Program: Vaccines to prevent meningococcal disease. Resolution No. 6/19-7. https://www.cdc.gov/vaccines/programs/vfc/downloads/resolutions/2019-6-7-mening-508.pdf. Effective June 27, 2019. Accessed February 4, 2020.

BEXWCNT200001 March 2020